All evidence from our study demonstrates that TRIM68, PIKFYVE, and DYNLL2 are high-risk genes involved in the development of osteosarcoma and can be used as biomarkers for predicting the prognosis of osteosarcoma. Here, DYNLL2 is linked to osteosarcoma.